Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Revenue

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹14,278 Cr₹12,207 Cr₹10,260 Cr₹8,749 Cr₹7,782 Cr

What is the latest Revenue of MANKIND PHARMA ?

The latest Revenue ratio of MANKIND PHARMA is ₹14,278 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹14,278 Cr
Mar2025₹12,207 Cr
Mar2024₹10,260 Cr
Mar2023₹8,749 Cr
Mar2022₹7,782 Cr

How is Revenue of MANKIND PHARMA Trending?

Years Revenue % Change
Mar2026 ₹14,278 Cr
16.96
Mar2025 ₹12,207 Cr
18.98
Mar2024 ₹10,260 Cr
17.27
Mar2023 ₹8,749 Cr
12.44
Mar2022 ₹7,782 Cr -

Compare Revenue of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,194.8 Cr -5.5% -2.2% -5.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,870.0 Cr -1.4% 2.4% 17.1% Stock Analytics
DIVIS LABORATORIES ₹220,946.0 Cr 12.2% 23.1% 21.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,907.0 Cr 2.4% 5.3% 41.7% Stock Analytics
CIPLA ₹118,674.0 Cr 1.7% 0.7% -3.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,648.7 Cr 3% -14.9% -10.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-5.5%

-2.2%

-5.1%

SENSEX

2.4%

1.5%

-4.3%


You may also like the below Video Courses